Metabolic syndrome (MetS) is a cluster of cardiovascular disease risk factors that are related to several adverse health outcomes, including poor cognitive function. This review seeks to summarize and critically review select recent findings on the association between MetS and cognition. MetS was associated with lower domain-specific and global cognitive function in most cross-sectional studies, but findings from longitudinal studies are not consistent. The associations varied depending on age, sex, cognitive test, genetic susceptibility, and the duration of follow-up in prospective studies. MetS was associated with a higher risk of mild cognitive impairment (MCI) and progression from MCI to dementia, particularly vascular dementia. Among MetS components, high blood pressure, high waist circumference, and hyperglycemia were the strongest predictors of cognitive function. MetS is associated with higher risk of cognitive impairment. Research is needed on how preventing or treating MetS affects cognition. © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Citation
Mouna Tahmi, Priya Palta, José A Luchsinger. Metabolic Syndrome and Cognitive Function. Current cardiology reports. 2021 Oct 19;23(12):180
Mesh Tags
PMID: 34668083
View Full Text
